Clevidipine for severe hypertension in patients with renal dysfunction: A VELOCITY trial analysis

Introduction. Acute and severe hypertension is common, especially in patients with renal dysfunction (RD). Clevidipine is a rapidly acting (t½∼1 min) intravenous (IV) dihydropyridine calcium-channel blocker metabolized by blood and tissue esterases and may be useful in patients with RD. The purpose...

Descripción completa

Detalles Bibliográficos
Autores principales: PEACOCK, W FRANK, VARON, JOSEPH, EBRAHIMI, RAMIN, DUNBAR, LALA, POLLACK, CHARLES V
Formato: Texto
Lenguaje:English
Publicado: Informa Healthcare 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038587/
https://www.ncbi.nlm.nih.gov/pubmed/21091269
http://dx.doi.org/10.3109/08037051.2010.539317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038587/
https://www.ncbi.nlm.nih.gov/pubmed/21091269
http://dx.doi.org/10.3109/08037051.2010.539317

Ejemplares similares